BridgeBio Oncology Therapeutics, Inc. Long-term Investment Intensity
BridgeBio Oncology Therapeutics, Inc. long-term investment intensity. BridgeBio Oncology Therapeutics, Inc. (BBOT) has a Long-term Investment Intensity of 32.7% as of March 2026. Long-term investments of $136.62 Million represent 32.7% of total assets of $417.65 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of BridgeBio Oncology Therapeutics, Inc. for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BridgeBio Oncology Therapeutics, Inc. Long-term Investment Intensity by Year (None–None)
BridgeBio Oncology Therapeutics, Inc. long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for BridgeBio Oncology Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of BridgeBio Oncology Therapeutics, Inc..
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|